Aliskiren/valsartan combination regulatory update

Novartis submitted an NDA to FDA for a single pill combination of its Tekturna/ Rasilez aliskiren and Diovan valsartan to treat hypertension. Novartis already markets aliskiren, a renin inhibitor, ...